Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

3.90
Delayed Data
As of Mar 24
 +0.55 / +16.42%
Today’s Change
1.10
Today|||52-Week Range
3.95
+188.89%
Year-to-Date
Health Care Vote Impacts Trump's Deal Maker Image
Mar 23 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close3.35
Today’s open3.50
Day’s range3.30 - 3.95
Volume1,867,079
Average volume (3 months)235,992
Market cap$73.9M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+48.98%
Earnings growth (this year)--
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+49.94%
P/E ratioNM
Price/Sales0.79
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
GALTGalectin Therapeutic...+0.07+3.29%
TRILTrillium Therapeutic...+0.15+2.52%
VRMLVermillion Inc0.000.00%
INISInternational Isotop...+0.00+2.47%
Data as of 3:59pm ET, 03/24/2017

Financials

Last reporting dateMarch 23, 2017
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$27.0M
Annual profit (last year)-$15.8M
Net profit margin-58.42%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
President, Chief Executive Officer &
Director
Panna L. Sharma
Chief Operating Officer &
Executive VP-Finance
John A. Roberts
Corporate headquarters
Rutherford, New Jersey

Forecasts


Search for Jobs